|
Report No. : |
307359 |
|
Report Date : |
16.02.2015 |
IDENTIFICATION DETAILS
|
Name : |
STRATEGIC SCIENCE & TECHNOLOGIES-C LLC |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
United State |
|
|
|
|
Date of Incorporation : |
27.08.2012 |
|
|
|
|
Legal Form : |
LLC |
|
|
|
|
Line of Business : |
Specialty in
Pharmaceuticals. |
|
|
|
|
No. of Employee : |
1 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
United State |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
UNITED STATE ECONOMIC OVERVIEW
The US has the largest and most technologically powerful economy in the world, with a per capita GDP of $49,800. In this market-oriented economy, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, they face higher barriers to enter their rivals' home markets than foreign firms face entering US markets. US firms are at or near the forefront in technological advances, especially in computers and in medical, aerospace, and military equipment; their advantage has narrowed since the end of World War II. The onrush of technology largely explains the gradual development of a "two-tier labor market" in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income. Imported oil accounts for nearly 55% of US consumption. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the United States into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression. To help stabilize financial markets, in October 2008 the US Congress established a $700 billion Troubled Asset Relief Program (TARP). The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009 the US Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012 the federal government reduced the growth of spending and the deficit shrank to 7.6% of GDP. Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2011, the direct costs of the wars totaled nearly $900 billion, according to US government figures. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries. In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that was designed to extend coverage to an additional 32 million American citizens by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on health care - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010. In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight. In December 2012, the Federal Reserve Board (Fed) announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short term rates near zero until unemployment drops below 6.5% or inflation rises above 2.5%. In late 2013, the Fed announced that it would begin scaling back long-term bond purchases to $75 billion per month in January 2014 and reduce them further as conditions warranted; the Fed, however, would keep short-term rates near zero so long as unemployment and inflation had not crossed the previously stated thresholds. Long-term problems include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits.
|
Source
: CIA |
STRATEGIC SCIENCE
& TECHNOLOGIES-C LLC
Address: 58 Charles Street,
Cambridge, MA 02141 - USA
Telephone: +1
617-299-4789
Fax: +1 617-995-2420
Website: www.strategicscience.com
Corporate ID#: 5204027
State: Delaware
Judicial form: LLC
Date incorporated: 08-27-2012
Stock: -
Value: -
Name of manager: Eric
FOSSEL
Business:
Specialty pharmaceuticals.
Strategic Science & Technologies, LLC group of companies are a
clinical stage biotechnology company bringing a new level of innovation to the
field of localized transdermal drug delivery.
Office of the Foreign
Assets Control (OFAC):
The company is not listed on the OFAC list.
The Specially Designated Nationals (SDN) List is a publication of OFAC
which lists individuals and organizations with whom United States citizens and
permanent residents are prohibited from doing business.
No name of foreign suppliers available.
EIN: 46-0960863
Staff: 1
Operations & branches:
At the headquarters, we
find the corporate office and laboratory.
Shareholders:
STRATEGIC SCIENCE & TECHNOLOGIES LLC
58 Charles Street, Cambridge, MA 02141
Strategic Science & Technologies, LLC, a drug delivery company,
provides a technology to drive active pharmaceutical ingredients across skin.
It offers KNOSIS, a platform technology that enables pharmaceutical and
life science companies to deliver pharmaceutical agents transdermally for the
treatment of a host of conditions.
The company’s KNOSIS is used in various therapeutic areas, such as
genital herpes, neuropathic pain, hives, acne, nail fungus, erectile
dysfunction, Raynaud's disease, psoriasis, inflammation and pain, migraine
headaches, female sexual dysfunction, and hair loss.
Strategic Science & Technologies, LLC was founded in 1995 and is
based in Cambridge, Massachusetts
Management:
The Managers are:
- Eric FOSSEL
- Mike AUSTIN
- John GILLIS
- Daniel S. PETERS
Dr. Eric T. FOSSEL, Ph.D. founded Strategic Science & Technologies,
Inc. in 1955 and serves as its Chief Executive Officer.
Dr. Fossel serves as Chief Executive Officer of Strategic Science &
Technologies, LLC. He serves as an Advisor of San-Mar Laboratories, Inc.
After three years of intense laboratory work, he developed a system for
the transdermal delivery of L-Arginine. He was one amongst the Researchers, who
discovered the role of nitric oxide in controlling local blood flow, which was
one of the most important medical discoveries of the 1990's. He was the shared
winner of 1998 Nobel Prize for this discovery. He filed several patents on this
system and its applications and six US patents and four international patents
have been issued while numerous other applications are pending, both in the US
and internationally. He served as Director of Research in Radiology at Beth
Israel Hospital and Harvard Medical School.
He was Professor of Radiology at Beth Israel Hospital and Harvard
Medical School. For twenty-five years, from 1970 to 1995, he was a member of
the faculty of Harvard Medical School, working in several departments and in
several fields. He was made an Established Investigator of the American Heart
Association for his work on cardiac metabolism with magnetic resonance imaging
(MRI). He was instrumental in establishing the first human MRI program in the
world at Massachusetts General Hospital in the late 1970s. He also worked on
cancer diagnosis and treatment, red blood cell metabolism and peptide and
protein structure, among other topics. Dr. Fossel is the author of more than
100 peer-reviewed articles, chapters and monographs and has presented more than
230 papers at scientific meetings. He has been granted numerous patents in the
fields of MRI and cancer diagnosis and treatment and the transdermal delivery
of APIs. Dr. Fossel obtained his BA, MS and MPhil degrees from Yale University
in the field of Chemistry.
He obtained his PhD in Chemistry and MTS in Theology from Harvard
University.
Michael M. Austin has been Chief Financial Officer of Strategic Science
& Technologies, LLC (SST) since joining in 2004 and serves as its
Treasurer.
Mr. Austin has broad experience in banking, project finance and start up
of new companies. He worked for 32 years in banking and finance in Indonesia,
Nigeria, Kenya and Saudi Arabia. The majority of those years were spent with
Citibank and its affiliates. From 1987 to 1990, Mr. Austin worked with Shearson
Lehman Hutton in Riyadh, where he advised Saudi Economic Offset Committee on
the structure and start up of new companies. From 1990 to 1995,
he served as Chief Financial Officer of Alujain Corp. He served for one
year as a German teacher and three years as a Chemist. He speaks Norwegian and
German, and Indonesian. He captained Yale's swim team in 1964 and was a Member
of the 1964 Olympic Swim Team, winning a Gold Medal in the 4 x 100 meter
freestyle relay.
Mr. Austin has a BA in Chemistry at Yale.
He has an MBA from Harvard Business School.
As far as we know,
they are involved in other corporations, including:
STRATEGIC SCIENCE & TECHNOLOGIES LLC
STRATEGIC SCIENCE & TECHNOLOGIES-A, LLC
STRATEGIC SCIENCE & TECHNOLOGIES-D LLC
STRATEGIC SCIENCE & TECHNOLOGIES-F LLC
STRATEGIC SCIENCE & TECHNOLOGIES-H LLC
STRATEGIC SCIENCE & TECHNOLOGIES-I LLC
In United States, privately
held corporations are not required to publish any financials.
On a direct call, nobody
accepted to answer our questions.
We sent a fax but no answer
received.
No financials available.
Banks: n/a
Legal filings
& complaints:
As of today date, there is no legal filing pending with the Courts.
Secured debts summary (UCC):
None